🎢 Your Options Alert for Dec 19 (Friday)

Phase 2 Trials Incoming - Could NNVC Be the Next Biotech Giant? (ad)*

Dear Reader,

I hope you are having a great Friday and also hope you have a good weekend ahead of you! I am sending you the list of options signals for the next trading day (to help you cut your research in finding trading and/or investing opportunities).

📈 Analysts Forecast 5x Upside: A Game-Changing Biotech Story Unfolding (ad)*

A small-cap biotech is advancing a first-of-its-kind antiviral designed to neutralize viruses before infection.

With Phase 2 trials targeting MPox, measles, and respiratory viruses—and potential U.S. biodefense applications—Wall Street is starting to pay attention.

NV-387 may very well be the world’s next great antiviral defense — and NanoViricides, Inc. (NYSE: NNVC) could be the top name in biotech to watch in 2026!

See Why Zacks Issued a $7 Valuation on This Antiviral Play

Stock Name	Signal Date	Signal Name
META	Dec 19	Golden Crossover
NFLX	Dec 19	Golden Crossover
KO	Dec 19	Golden Crossover
MCD	Dec 19	Golden Crossover
SONY	Dec 19	Below 200-MA
SPGI	Dec 19	Below 200-MA
DE	Dec 19	Below 200-MA
COP	Dec 19	Below 200-MA
JPM	Dec 19	Double Top
LRCX	Dec 19	Double Top
APH	Dec 19	Double Top
TRP	Dec 19	Double Top
CHKP	Dec 19	Double Bottom
IT	Dec 19	Double Bottom
CAG	Dec 19	Double Bottom
ATR	Dec 19	Double Bottom
Click Here to View Your Full Report

Major Trial Phase Puts This Biotech Center Stage (ad)*

A little-known biotech is quietly preparing what could be one of the most important antiviral breakthroughs of the decade.

NanoViricides (NYSE: NNVC) is advancing NV-387 — a broad-spectrum antiviral designed to neutralize viruses before they infect cells. With Phase 2 trials targeting MPox, measles, and respiratory viruses ahead — and Zacks issuing a $7 valuation — this small-cap story is starting to turn heads on Wall Street.

Few investors are paying attention… yet.

👉 See Why Analysts Are Watching This Antiviral Breakout Now

How to use signals in your trading/investing strategies:

Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's trade signal) or the Price Reversal strategy (to target the reversal following signal generation). Please click on Ride-the-Wave Strategy to learn more about it.

Stock Trading - If you're a swing stock trader/investor or portfolio manager, you may want to consider entering or exiting your positiosn based on a the signal generation. Please click on Volatility Crush Strategy to learn more about it.

With a $7 Valuation, NNVC Could Shake Up the Biotech Space in 2026 (ad)*

This emerging biotech company is advancing a broad-spectrum antiviral into Phase 2 trials, with potential applications in public health and biodefense.

New research highlights upcoming catalysts that could significantly impact its future trajectory.

Learn why NNVC is on the verge of redefining the antiviral market

At Options Hero, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader.

To your trading success,

Support Team

Options Hero

PS:Options Hero is morning newsletter, powered by StockEarnings proprietary technology.

📈 Beat Volatility with These Dividend Powerhouses

After the recent market volatility, income picks are in hot demand. Our free report teases High-Yield Dividend Stocks that could anchor your returns:

📥 [Download Your Free Guide Now] .

(ad)* This message is a PAID ADVERTISEMENT for NanoViricides, Inc (NYSE:NNVC) from Interactive Offers. Options Hero, Inc and StockEarnings, Inc has received a fixed fee of $8000 from Interactive Offers for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between Dec 19, 2025 and Dec 25, 2025. Other than the compensation received for this advertisement sent to subscribers, Options Hero and StockEarnings and its principals are not affiliated with either NanoViricides, Inc (NYSE:NNVC) or Interactive Offers. Options Hero and StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither Options Hero and StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Options Hero and StockEarnings to buy or sell any security. Options Hero and StockEarnings has not evaluated the accuracy of any claims made in this advertisement. Options Hero and StockEarnings recommends that investors do their own independent research and consult with a qualified investment

Options Hero is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities.

This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised.

All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers.

🎢 Your Options Alert for Dec 19 (Friday)

0 Response to "🎢 Your Options Alert for Dec 19 (Friday)"

Post a Comment